| Radiopharmaceutical enhancement by drug delivery systems: A review J Kleynhans, AF Grobler, T Ebenhan, MM Sathekge, JR Zeevaart Journal of controlled release 287, 177-193, 2018 | 30 | 2018 |
| A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for … IO Lawal, KMG Mokoala, J Mahapane, J Kleyhans, M Meckel, M Vorster, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 134-142, 2021 | 26 | 2021 |
| A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma J Bolcaen, J Kleynhans, S Nair, J Verhoeven, I Goethals, M Sathekge, ... Theranostics 11 (16), 7911, 2021 | 22 | 2021 |
| Production of [68Ga]Ga‐PSMA: Comparing a manual kit‐based method with a module‐based automated synthesis approach J Kleynhans, S Rubow, J le Roux, B Marjanovic‐Painter, JR Zeevaart, ... Journal of Labelled Compounds and Radiopharmaceuticals 63 (13), 553-563, 2020 | 16 | 2020 |
| Obstacles and recommendations for clinical translation of nanoparticle system-based targeted alpha-particle therapy J Kleynhans, M Sathekge, T Ebenhan Materials 14 (17), 4784, 2021 | 12 | 2021 |
| Non-oncological applications of RGD-based single-photon emission tomography and positron emission tomography agents T Ebenhan, J Kleynhans, JR Zeevaart, JM Jeong, M Sathekge European Journal of Nuclear Medicine and Molecular Imaging 48, 1414-1433, 2021 | 12 | 2021 |
| A decade of ubiquicidin development for PET imaging of infection: A systematic review B Marjanovic-Painter, J Kleynhans, JR Zeevaart, E Rohwer, T Ebenhan Nuclear Medicine and Biology 116, 108307, 2023 | 10 | 2023 |
| The use of HEPES-buffer in the production of gallium-68 radiopharmaceuticals–time to reconsider strict pharmacopoeial limits? J Le Roux, J Kleynhans, S Rubow EJNMMI Radiopharmacy and Chemistry 6, 1-4, 2021 | 9 | 2021 |
| Fundamentals of rhenium-188 radiopharmaceutical chemistry J Kleynhans, A Duatti, C Bolzati Molecules 28 (3), 1487, 2023 | 8 | 2023 |
| In silico modelling in the development of novel radiolabelled peptide probes J Kleynhans, HG Kruger, T Cloete, JR Zeevaart, T Ebenhan Current Medicinal Chemistry 27 (41), 7048-7063, 2020 | 6 | 2020 |
| Preclinical Research highlighting contemporary targeting mechanisms of radiolabelled compounds for PET based infection imaging J Kleynhans, MM Sathekge, T Ebenhan Seminars in Nuclear Medicine, 2023 | 4 | 2023 |
| A toxicity profile of the Pheroid® technology in rodents J Kleynhans, D Elgar, T Ebenhan, JR Zeevaart, A Kotzé, A Grobler Toxicology Reports 6, 940-950, 2019 | 4 | 2019 |
| Single Photon Emission Tomography in the Diagnostic Assessment of Cardiac and Vascular Infectious Diseases IO Lawal, J Kleyhans, KMG Mokoala, M Vorster, T Ebenhan, JR Zeevaart, ... Current Radiopharmaceuticals 14 (3), 242-258, 2021 | 3 | 2021 |
| The determination of the radiochemical purity of Actinium-225 radiopharmaceuticals: a conundrum J Kleynhans, A Duatti EJNMMI Radiopharmacy and Chemistry 7 (1), 23, 2022 | 2 | 2022 |
| Spotlight: the status of radiopharmacy in Africa J Kleynhans, B Summers, T Sakr, JR Zeevaart, M Lundie, S Du Plessis, ... Clinical and Translational Imaging, 1-6, 2023 | | 2023 |
| Biodosimetry, can it find its way to the Nuclear Medicine clinic? J Bolcaen, N Combrink, K Spoormans, S More, C Vandevoorde, R Fisher, ... Frontiers in Nuclear Medicine 3, 1209823, 2023 | | 2023 |
| Elucidating the effect of specific surface area on the gastrointestinal absorption of nanostructured calcium through Calcium-45 in vivo radiotracing J Kleynhans, T Cloete, HC Dunn, L Posavec, AF Grobler, ... Applied Radiation and Isotopes 173, 109702, 2021 | | 2021 |
| Correction to: Non-oncological applications of RGD-based single-photon emission tomography and positron emission tomography agents T Ebenhan, K Janke, ZJ Rijn, JM Jeong, S Mike European Journal of Nuclear Medicine and Molecular Imaging 48 (5), 1695-1695, 2021 | | 2021 |
Thomas Ebenhan在 up.ac.za 的电子邮件经过验证
